Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.

Xu Y, Boyle TA, Lyu B, Ballew SH, Selvin E, Chang AR, Inker LA, Grams ME, Shin JI.

Open source

DOI
10.1007/s11606-023-08589-3
Published
2024-01-08
Container
J Gen Intern Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11606-023-08589-3,
  title = {Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.},
  author = {Xu Y and  Boyle TA and  Lyu B and  Ballew SH and  Selvin E and  Chang AR and  Inker LA and  Grams ME and  Shin JI.},
  year = {2024},
  journal = {J Gen Intern Med},
  doi = {10.1007/s11606-023-08589-3},
  url = {https://doi.org/10.1007/s11606-023-08589-3}
}

RIS

TY  - JOUR
TI  - Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.
AU  - Xu Y
AU  -  Boyle TA
AU  -  Lyu B
AU  -  Ballew SH
AU  -  Selvin E
AU  -  Chang AR
AU  -  Inker LA
AU  -  Grams ME
AU  -  Shin JI.
PY  - 2024
JO  - J Gen Intern Med
DO  - 10.1007/s11606-023-08589-3
UR  - https://doi.org/10.1007/s11606-023-08589-3
ER  - 

APA

Y, X., TA, B., B, L., SH, B., E, S., AR, C., LA, I., ME, G., & JI., S. (2024). Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.. J Gen Intern Med. https://doi.org/10.1007/s11606-023-08589-3

Source records